Results 161 to 170 of about 2,670,442 (349)

Role of immunoturbidimetric plasma fibrin D-dimer test in patients with coronary artery disease as well as ischemic heart disease in emergency medicine [PDF]

, 2011
The aim of the present was to assess the value of the ELISA D-dimer (hemostatic marker) assay in patients with coronary artery disease as well as ischemic heart disease presenting to the emergency department with chest pain syndrome. Methods: We measured
Ajay K. Singh , Vikas Gupta, Neelima Singh, Sanjeev K. Singh , Nivedita Singh, Arun Raiza, Harshverdhan Singh , Int J Cur Biomed Phar Res.
core  

Some aspects of stable angina treatment: risk of complications assessment in a combined course with COPD

, 2014
В. К. Тащук, T. Amelina, A. S. Polianska, О. I. Hulaga   +3 more
openalex   +2 more sources

Compound Danshen dripping pills for stable angina: Meta-analysis of randomized controlled trials [PDF]

, 2011
Yafeng Li, Yanli Wang, Qi Yu, Kena Wei, Meng Li, Sihai Zhao, Yuzuru Kurabayashi, Jianglin Fan, Enqi Liu   +8 more
openalex   +1 more source

Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial

The Lancet, 2018
R. Al-Lamee, D. Thompson, Hakim-Moulay Dehbi, S. Sen, K. Tang, J. Davies, Thomas R. Keeble, Michael Mielewczik, R. Kaprielian, I. Malik, S. Nijjer, R. Petraco, Christopher M. Cook, Y. Ahmad, J. Howard, C. Baker, A. Sharp, R. Gerber, S. Talwar, R. Assomull, J. Mayet, R. Wensel, D. Collier, M. Shun-shin, S. Thom, J. Davies, D. Francis, A. Sethi, P. Ramrakha, R. Foale, R. Khamis, N. Hadjiloizou, Masood Khan, J. Kooner, Michael F Bellamy, G. Mikhail, P. Clifford, P. O'Kane, T. Levy, R. Swallow   +39 more
semanticscholar   +1 more source

Comparing the Molecular Pharmacological Properties of Existing β‐Blockers to Determine the Theoretically Most “Ideal” Anti‐Cancer β‐Blocker

Pharmacology Research &Perspectives, Volume 14, Issue 1, February 2026.
ABSTRACT There is increasing evidence, from cellular, animal and human epidemiological studies, linking β‐blockers with reductions in cancer growth and metastasis. Propranolol is the most investigated β‐blocker for cancer; although as many different off‐patent β‐blockers exist, there is little commercial incentive to drive comparative clinical trials ...
Jillian G. Baker
wiley   +1 more source

Quantifying stent‐induced dose perturbations in intravascular brachytherapy using 3D‐ printed phantoms and film dosimetry

Journal of Applied Clinical Medical Physics, Volume 27, Issue 1, January 2026.
Abstract Background Coronary artery disease (CAD), the leading cause of death worldwide, is the narrowing of coronary arteries due to atherosclerotic plaque buildup. A common treatment for CAD is percutaneous coronary intervention (PCI), often involving stent placement. However, a common complication or in‐stent restenosis (ISR) can occur in 10%–20% of
Jessica S. Jung, Lyu Huang, Nicholas Coupera, Yijian Cao, Jenghwa Chang   +4 more
wiley   +1 more source

CARDIOPROTECTION POTENTIAL IN CORONARY HEART DISEASE TREATMENT

Российский кардиологический журнал, 2009
Aim. To investigate effectiveness and safety of trimetazidine MB in the complex treatment of stable angina. In total, 90 patients were examined – 57 women and 33 men aged 48-70 years (mean age 61,4 ± 6,03 years).
N. A. Shostak, O. G. Smolenskaya, A. V. Panov, A. A. Klimenko, D. Yu. Andriyashkina, N. A. Tverdova   +5 more
doaj  

Outcomes of an Intravenous to Subcutaneous Infliximab (CT‐P13) Strategy in Takayasu Arteritis: A Proof‐of‐Concept Prospective Study

ACR Open Rheumatology, Volume 8, Issue 1, January 2026.
Objectives To evaluate persistence, outcomes, safety, and remission maintenance after switching from intravenous infliximab (IV‐IFX) to subcutaneous infliximab (SC‐IFX, CT‐P13) in patients with Takayasu arteritis (TA). Methods We conducted a prospective, single‐center, proof‐of‐concept observational study of consecutive adults with TA in sustained ...
Luca Iorio, Federica Davanzo, Eleonora Fiorin, Marta Codirenzi, Roberta Prevedello, Andrea Doria, Roberto Padoan   +6 more
wiley   +1 more source

Effectiveness and Tolerability of Trimetazidine 80 mg Once Daily in Patients with Chronic Coronary Syndrome in Brazil: The V-GOOD Observational Study

Cardiology and Therapy
Introduction The V-GOOD study evaluated the effectiveness of trimetazidine modified-release (MR) 80 mg once daily (OD) in patients with chronic coronary syndrome (CCS) who remained symptomatic despite antianginal therapies in routine clinical practice ...
Luís Henrique Wolff Gowdak, Paulo Magno Martins Dourado, Dalton Bertolim Précoma, César de Oliviera Lopes Dusilek, Francisco Maia da Silva, Juan Carlos Yugar-Toledo, Felipe Montes Pena, Domingos Antônio de Almeida Gomes, Elizabeth do Espírito Santo Cestário, Olavo Raimundo Guimarães, Conrado Roberto Hoffmann Filho, Carlos Filinto de Almeida, Flávio de Souza Brito, Gerez Fernandes Martins, Victor Rodrigues Ribeiro Ferreira, Marcella Chaves Flores, Mayara Lídia da Silva, on behalf of the V-GOOD Investigators   +17 more
doaj   +1 more source

Comparison between Revascularization and Optimal Medical Therapy in Patients with Stable Angina Pectoris [PDF]

, 2016
Maryam Nabati, Ehsan Vazirian, Ali Ghaemian, Jamshid Yazdani Charati, Maryam Hosseinzadeh   +4 more
openalex   +1 more source